Saluda Medical logo

Saluda Medical Pty Ltd


Saluda Medical Stock

Saluda Medical developers closed-loop neuron modulation devices intended to treat chronic neuropathic pain. The company's devices are used for the patient's neural fingerprint to monitor and adapt the dose of electrical stimulation automatically and tailor the therapy to meet each patient's needs in real-time, enabling patients with chronic back pain to get improved treatment.

Management Team

Jim Schuermann President and Chief Executive Officer
James Erickson Chief Financial Officer
Robert Gaffney Chief Operating Officer
Dan Brounstein Chief Strategy Officer
Peter Single Chief Technology Officer
Yolanda Blasing Chief Accounting Officer
Kristin Caplice Chief Legal Officer
Tim Benner Chief Commercial Officer
Steven McQuillan Chief Clinical and Regulatory Officer

Funding Information